NCT03147638Unknown3 期
Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 入组人数
- 70
- 试验地点
- 1
- 主要终点
- All cause hospitalization
研究概览
简要总结
Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 97 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •Patient is unable to sign an informed consent
- •Patient doesn't have a confirmed diagnosis of HIT
- •Patient Does not have Pulmonary embolus
- •Patient does is not on Warfarin for other indications
- •Patient is a known case of hypercoagulable disorder
- •Patient is not willing to come back for follow up
- •Patient is critically ill or has a life expectancy of less than 3 months
- •Pregnancy that is in First trimester.
- •Multi-system organ failure or estimated survival of less than 30 days
- •Uncontrolled hypertension defined as a blood pressure >180/110 mm Hg
研究组 & 干预措施
1 month
Experimental
patient treated with Anti coagulation for one month
干预措施: Warfarin, NOAC (Drug)
3 months
Active Comparator
standard of care , treatment for 3 months
干预措施: Warfarin, NOAC (Drug)
结局指标
主要结局
All cause hospitalization
时间窗: Within six months after treatment
side effects of Warfarin treatment
时间窗: Within six months after treatment
All cause mortality
时间窗: Within six months after treatment
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Clinical Study on the Efficacy and Safety of Hetropapa Ethanolamine Tablets in the Treatment of Thrombocytopenia Caused by Concurrent Radiotherapy and Chemotherapy in Cervical CancerTumor Chemotherapy-related ThrombocytopeniaNCT05160857Second Hospital of Shanxi Medical University30
招募中
2 期
A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCCMacrotrabecular Massive Hepatocellular CarcinomaNCT05839197Wan-Guang Zhang38
招募中
不适用
Efficacy and Safety of CSA and Avatrombopag for the Treatment of SAA in the ElderlySevere Aplastic AnemiaNCT05433922Institute of Hematology & Blood Diseases Hospital, China80
已完成
2 期
Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/VelpatasvirAcute Hepatitis CHepatitis CNCT03818308Hannover Medical School20
招募中
2 期
Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic AnemiaTPO Receptor AgonistsAplastic AnemiaNCT06613880Institute of Hematology & Blood Diseases Hospital, China48